top
Search terms
Results 1 - 3 of 3 - ordered by :
Ehjcardiovascrec

Abstract Objectives: HMG CoA reductase inhibitors reduce cellular availability of mevalonate, a precursor in cholesterol synthesis. Since the cholesterol content of cell membranes is an important ...

Cardiovascular Research, Original Article, David F Gray, Henning Bundgaard, Peter S Hansen, Kerrie A Buhagiar, Anastasia S Mihailidou, Wendy Jessup, Keld Kjeldsen, Helge H Rasmussen

Date : 01/08/2000
Ehjcardiovascrec

Abstract Objectives: HMG CoA reductase inhibitors reduce cellular availability of mevalonate, a precursor in cholesterol synthesis. Since the cholesterol content of cell membranes is an important ...

Cardiovascular Research, Gray, David F, Bundgaard, Henning, Hansen, Peter S, Buhagiar, Kerrie A, Mihailidou, Anastasia S, Jessup, Wendy, Kjeldsen, Keld, Rasmussen, Helge H

Date : 01/08/2000 Item size : 246847 bytes
Ehjcardiovascrec

Abstract Objectives: HMG CoA reductase inhibitors reduce cellular availability of mevalonate, a precursor in cholesterol synthesis. Since the cholesterol content of cell membranes is an important ...

Cardiovascular Research, Gray, David F, Bundgaard, Henning, Hansen, Peter S, Buhagiar, Kerrie A, Mihailidou, Anastasia S, Jessup, Wendy, Kjeldsen, Keld, Rasmussen, Helge H

Date : 01/08/2000 Item size : 235798 bytes